Cargando…
Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis
Research into the heterogeneous nature of cognitive impairment documented in patients with Parkinson's disease (PD) has focused on disentangling deficits that vary between individuals, evolve and respond differentially to pharmacological treatments, and relate differentially to PD dementia (PDD...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079071/ https://www.ncbi.nlm.nih.gov/pubmed/23038420 http://dx.doi.org/10.1159/000341998 |
_version_ | 1782462511621079040 |
---|---|
author | Kehagia, Angie A. Barker, Roger A. Robbins, Trevor W. |
author_facet | Kehagia, Angie A. Barker, Roger A. Robbins, Trevor W. |
author_sort | Kehagia, Angie A. |
collection | PubMed |
description | Research into the heterogeneous nature of cognitive impairment documented in patients with Parkinson's disease (PD) has focused on disentangling deficits that vary between individuals, evolve and respond differentially to pharmacological treatments, and relate differentially to PD dementia (PDD). We summarise studies conducted in our laboratory over the last 2 decades, outlining the incremental development of our hypotheses, the starting point for which is our early work on executive deficits mirroring fronto-striatal dysfunction. We present subsequent findings linking these deficits to a model of dopaminergic function that conforms to an inverted curvilinear function. We review studies that investigated the range of dopamine-independent attentional and visuospatial memory deficits seen in PD, demonstrating that abnormalities in these domains more accurately predict PDD. We conclude with an exposition of the dual syndrome hypothesis, which distinguishes between dopaminergically mediated fronto-striatal executive impairments and a dementia syndrome with distinctive prodromal visuospatial deficits in which cholinergic treatments offer some clinical benefits. |
format | Online Article Text |
id | pubmed-5079071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-50790712016-10-27 Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis Kehagia, Angie A. Barker, Roger A. Robbins, Trevor W. Neurodegener Dis Paper Research into the heterogeneous nature of cognitive impairment documented in patients with Parkinson's disease (PD) has focused on disentangling deficits that vary between individuals, evolve and respond differentially to pharmacological treatments, and relate differentially to PD dementia (PDD). We summarise studies conducted in our laboratory over the last 2 decades, outlining the incremental development of our hypotheses, the starting point for which is our early work on executive deficits mirroring fronto-striatal dysfunction. We present subsequent findings linking these deficits to a model of dopaminergic function that conforms to an inverted curvilinear function. We review studies that investigated the range of dopamine-independent attentional and visuospatial memory deficits seen in PD, demonstrating that abnormalities in these domains more accurately predict PDD. We conclude with an exposition of the dual syndrome hypothesis, which distinguishes between dopaminergically mediated fronto-striatal executive impairments and a dementia syndrome with distinctive prodromal visuospatial deficits in which cholinergic treatments offer some clinical benefits. S. Karger AG 2012-11 2012-10-03 /pmc/articles/PMC5079071/ /pubmed/23038420 http://dx.doi.org/10.1159/000341998 Text en Copyright © 2012 by S. Karger AG, Basel http://creativecommons.org/licenses/by/4.0/ This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY) (http://www.karger.com/Services/OpenAccessLicense). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher. |
spellingShingle | Paper Kehagia, Angie A. Barker, Roger A. Robbins, Trevor W. Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title | Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title_full | Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title_fullStr | Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title_full_unstemmed | Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title_short | Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis |
title_sort | cognitive impairment in parkinson's disease: the dual syndrome hypothesis |
topic | Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079071/ https://www.ncbi.nlm.nih.gov/pubmed/23038420 http://dx.doi.org/10.1159/000341998 |
work_keys_str_mv | AT kehagiaangiea cognitiveimpairmentinparkinsonsdiseasethedualsyndromehypothesis AT barkerrogera cognitiveimpairmentinparkinsonsdiseasethedualsyndromehypothesis AT robbinstrevorw cognitiveimpairmentinparkinsonsdiseasethedualsyndromehypothesis |